Illumina advances personalized cancer care with new pharma development partnerships

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/26/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. PRME

Go back to Illumina advances personalized cancer care with new pharma development partnerships
Illumina, Inc. (NASDAQ: ILMN) Delayed: 270.00 -3.9 (1.42%)
Previous Close $273.90    52 Week High $196.47 
Open $272.16    52 Week Low $127.10 
Day High $276.97    P/E 300.00 
Day Low $267.66    EPS $0.90 
Volume 5,031,741